Decreased Mdm2 expression in Mdm2 heterozygous or hypomorphic mice delays tumor onset due to increased p53-mediated apoptosis, resulting in higher rates of p53 mutation and/or deletion in tumors that eventually develop [15,16]. This evidence concerns the gene MDM2 and neoplasm.